| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Huntsman Ronald Kirk is a Chief Executive Officer at Vivos Therapeutics, Inc.. Recent SEC Form 4 filings include 13 buys and 0 sells.
Estimated insider holdings value: $112K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 20, 2023 | VVOS Vivos Therapeutics, Inc. | Chief Executive Officer | Buy | 14,000 | $0.53 | $7,420.00 | +19.3% | |
| Jun 16, 2023 | VVOS Vivos Therapeutics, Inc. | Chief Executive Officer | Buy | 15,021 | $0.54 | $8,060.50 | +8.2% | |
| Jun 14, 2023 | VVOS Vivos Therapeutics, Inc. | Chief Executive Officer | Buy | 10,000 | $0.49 | $4,900.00 | +21.1% | |
| Dec 23, 2022 | VVOS Vivos Therapeutics, Inc. | Chief Executive Officer | Buy | 20,000 | $0.50 | $10,000.00 | +72.7% | |
| Jun 1, 2022 | VVOS Vivos Therapeutics, Inc. | Chief Executive Officer | Buy | 12,000 | $1.96 | $23,560.00 | +30.8% | |
| Sep 21, 2021 | VVOS Vivos Therapeutics, Inc. | Chief Executive Officer | Buy | 5,000 | $4.31 | $21,550.00 | +47.6% | |
| Aug 17, 2021 | VVOS Vivos Therapeutics, Inc. | Chief Executive Officer | Buy | 5,000 | $3.00 | $15,000.00 | +90.9% | |
| May 25, 2021 | VVOS Vivos Therapeutics, Inc. | Chief Executive Officer | Buy | 4,000 | $5.38 | $21,520.00 | +266.7% | |
| Dec 23, 2020 | VVOS Vivos Therapeutics, Inc. | Chief Executive Officer | Buy | 1,000 | $7.27 | $7,266.90 | +200.0% | |
| Dec 11, 2020 | VVOS Vivos Therapeutics, Inc. | Chief Executive Officer | Buy | 500 | $8.50 | $4,250.00 | New |